Fig 3 - by Qingqing Hao (5464070)

Subjects:

Melting curves. by Jingyan Yang (7120994)

“…Elevated OIP5-AS1 expression was associated with an increased incidence of apoptosis. The silencing of OIP5-AS1 in I/R conditions resulted in a significant suppression of cell apoptosis, reduced cleavage of caspase-3, decreased Bax levels, and increased Bcl-2 levels. …”

Original blot and gel image data. by Jingyan Yang (7120994)

“…Elevated OIP5-AS1 expression was associated with an increased incidence of apoptosis. The silencing of OIP5-AS1 in I/R conditions resulted in a significant suppression of cell apoptosis, reduced cleavage of caspase-3, decreased Bax levels, and increased Bcl-2 levels. …”

Transfection sequences. by Jingyan Yang (7120994)

“…Elevated OIP5-AS1 expression was associated with an increased incidence of apoptosis. The silencing of OIP5-AS1 in I/R conditions resulted in a significant suppression of cell apoptosis, reduced cleavage of caspase-3, decreased Bax levels, and increased Bcl-2 levels. …”

Experimental data. by Jingyan Yang (7120994)

“…Elevated OIP5-AS1 expression was associated with an increased incidence of apoptosis. The silencing of OIP5-AS1 in I/R conditions resulted in a significant suppression of cell apoptosis, reduced cleavage of caspase-3, decreased Bax levels, and increased Bcl-2 levels. …”

Adjusted odds ratios of skilled delivery and skilled delivery with MAMA kits with community-level variables added one by one (Continuous remittance exposure). by Chelsea Ducille (21540080)

Subjects:

Adjusted odds ratios of skilled delivery and skilled delivery with MAMA kits with community-level variables added one by one (Binary remittance exposure). by Chelsea Ducille (21540080)

Subjects:

Patient demographics. by Katrine Carlsen (5477300)

Subjects:

Association across weeks to treatment for three genera. by Katrine Carlsen (5477300)

Subjects:

Genera associated with FC, symptom score or week to treatment. by Katrine Carlsen (5477300)

Subjects:

Changes in alpha diversity in the weeks before anti-TNF-a treatment. by Katrine Carlsen (5477300)

Subjects:

Family clades associating with week to treatment, symptom score or FC. by Katrine Carlsen (5477300)

Subjects:

Alpha diversity measures across all 727 samples. by Katrine Carlsen (5477300)

Subjects:

Summary statistics for analysis of single genera clades. by Katrine Carlsen (5477300)

Subjects:

Abundance of the top 20 most abundant genera in one patient (Patient 1), across the weeks running up to treatment. by Katrine Carlsen (5477300)

Subjects:

Development of alpha diversity across weeks towards a new TNF treatment for each IBD disease subtype. by Katrine Carlsen (5477300)

Subjects:

Community composition of samples from five individuals show clustering of samples according to individual. by Katrine Carlsen (5477300)

Subjects:

Study taxonomy. by Katrine Carlsen (5477300)

Subjects:

Microbiome profile of the most abundant phyla in one patient (Patient 1), across 12 infliximab treatments (-1 is the week before treatment, -2 the two weeks before treatment, etc). by Katrine Carlsen (5477300)

Subjects:

S5 Fig - by Katrine Carlsen (5477300)

Subjects: